Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site

Background: Existing data on the association of metastatic sites and prognosis of patients with metastatic testicular malignancy are limited. In this study, the association of survival outcome and the prognostic value of different metastatic sites in patients with metastatic testicular cancer was in...

Full description

Bibliographic Details
Main Authors: Peihang Xu, Jun Wang, Mierxiati Abudurexiti, Shengming Jin, Junlong Wu, Yijun Shen, Dingwei Ye
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01495/full
_version_ 1818880823834705920
author Peihang Xu
Peihang Xu
Jun Wang
Jun Wang
Mierxiati Abudurexiti
Mierxiati Abudurexiti
Shengming Jin
Shengming Jin
Junlong Wu
Junlong Wu
Yijun Shen
Yijun Shen
Dingwei Ye
Dingwei Ye
author_facet Peihang Xu
Peihang Xu
Jun Wang
Jun Wang
Mierxiati Abudurexiti
Mierxiati Abudurexiti
Shengming Jin
Shengming Jin
Junlong Wu
Junlong Wu
Yijun Shen
Yijun Shen
Dingwei Ye
Dingwei Ye
author_sort Peihang Xu
collection DOAJ
description Background: Existing data on the association of metastatic sites and prognosis of patients with metastatic testicular malignancy are limited. In this study, the association of survival outcome and the prognostic value of different metastatic sites in patients with metastatic testicular cancer was investigated.Methods: A dataset from the Surveillance, Epidemiology and End Results (SEER) survey was selected for a retrospective metastatic testicular cancer cohort study. Patients with different metastatic sites were divided into corresponding groups for further analysis. Kaplan-Meier analysis with log-rank test was implemented for comparison of the survival distribution of cases. Multivariate Cox regression models were then applied to analyze the association of distant metastases with survival for all selected patients and subgroup based on different histological type with a single metastatic site.Results: A total of 1,661 patients treated for metastatic testicular malignant tumors between 2010 to 2016 were enrolled in this cohort study. Upon initial diagnosis, 61.9, 15.2, 6.7, 6.4, and 36.2% of patients were found to have lung, liver, bone, brain, and distant lymph nodes metastatic sites, respectively. Patients with lung, liver, or bone metastases showed more undesirable prognosis for overall survival (OS) and cancer-specific survival (CSS), in contrast with those with distant lymph node metastases (all P < 0.05). In comparison with patients with more than one metastatic site, those with a single metastasis had extended OS and CSS (both P < 0.001). In patients with a single metastatic site, Kaplan-Meier analysis and multivariate Cox regression demonstrated the association of bone and liver with the worst two groups of OS and CSS. Multivariate Cox models based on histological type showed different prognostic values of metastases in patients with seminoma or non-seminomatous germ cell tumors.Conclusion: There is much heterogeneity in the oncological outcome of site-specific metastatic patients. Metastatic profiles and the prognostic value of metastases are dependent on the histological type in TC patients. Distant lymph nodes and lung metastases indicate favorable prognostic factors, while bone and liver metastases indicate negative survival outcomes in TC.
first_indexed 2024-12-19T14:52:06Z
format Article
id doaj.art-eec882eed4f4427aaa050b4c8ef90b6e
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T14:52:06Z
publishDate 2020-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-eec882eed4f4427aaa050b4c8ef90b6e2022-12-21T20:16:49ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-01-01910.3389/fonc.2019.01495471527Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic SitePeihang Xu0Peihang Xu1Jun Wang2Jun Wang3Mierxiati Abudurexiti4Mierxiati Abudurexiti5Shengming Jin6Shengming Jin7Junlong Wu8Junlong Wu9Yijun Shen10Yijun Shen11Dingwei Ye12Dingwei Ye13Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaBackground: Existing data on the association of metastatic sites and prognosis of patients with metastatic testicular malignancy are limited. In this study, the association of survival outcome and the prognostic value of different metastatic sites in patients with metastatic testicular cancer was investigated.Methods: A dataset from the Surveillance, Epidemiology and End Results (SEER) survey was selected for a retrospective metastatic testicular cancer cohort study. Patients with different metastatic sites were divided into corresponding groups for further analysis. Kaplan-Meier analysis with log-rank test was implemented for comparison of the survival distribution of cases. Multivariate Cox regression models were then applied to analyze the association of distant metastases with survival for all selected patients and subgroup based on different histological type with a single metastatic site.Results: A total of 1,661 patients treated for metastatic testicular malignant tumors between 2010 to 2016 were enrolled in this cohort study. Upon initial diagnosis, 61.9, 15.2, 6.7, 6.4, and 36.2% of patients were found to have lung, liver, bone, brain, and distant lymph nodes metastatic sites, respectively. Patients with lung, liver, or bone metastases showed more undesirable prognosis for overall survival (OS) and cancer-specific survival (CSS), in contrast with those with distant lymph node metastases (all P < 0.05). In comparison with patients with more than one metastatic site, those with a single metastasis had extended OS and CSS (both P < 0.001). In patients with a single metastatic site, Kaplan-Meier analysis and multivariate Cox regression demonstrated the association of bone and liver with the worst two groups of OS and CSS. Multivariate Cox models based on histological type showed different prognostic values of metastases in patients with seminoma or non-seminomatous germ cell tumors.Conclusion: There is much heterogeneity in the oncological outcome of site-specific metastatic patients. Metastatic profiles and the prognostic value of metastases are dependent on the histological type in TC patients. Distant lymph nodes and lung metastases indicate favorable prognostic factors, while bone and liver metastases indicate negative survival outcomes in TC.https://www.frontiersin.org/article/10.3389/fonc.2019.01495/fullmetastatic testicular cancerprognosismetastatic sitenumber of metastasesSEER
spellingShingle Peihang Xu
Peihang Xu
Jun Wang
Jun Wang
Mierxiati Abudurexiti
Mierxiati Abudurexiti
Shengming Jin
Shengming Jin
Junlong Wu
Junlong Wu
Yijun Shen
Yijun Shen
Dingwei Ye
Dingwei Ye
Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
Frontiers in Oncology
metastatic testicular cancer
prognosis
metastatic site
number of metastases
SEER
title Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
title_full Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
title_fullStr Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
title_full_unstemmed Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
title_short Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site
title_sort prognosis of patients with testicular carcinoma is dependent on metastatic site
topic metastatic testicular cancer
prognosis
metastatic site
number of metastases
SEER
url https://www.frontiersin.org/article/10.3389/fonc.2019.01495/full
work_keys_str_mv AT peihangxu prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT peihangxu prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT junwang prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT junwang prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT mierxiatiabudurexiti prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT mierxiatiabudurexiti prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT shengmingjin prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT shengmingjin prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT junlongwu prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT junlongwu prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT yijunshen prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT yijunshen prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT dingweiye prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite
AT dingweiye prognosisofpatientswithtesticularcarcinomaisdependentonmetastaticsite